Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brewer

Showing results (11-20 of 985) with videos related to

Pageof 99
Sort By:
Experimental Biology and Medicine (Maywood, N.J.)|July 11, 2001
Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's diseaseG J Brewer
Current Opinion in Chemical Biology|April 26, 2003
Copper in medicineGeorge J Brewer
Journal of Cellular and Molecular Medicine|May 28, 2003
Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammationG J Brewer
Experimental Gerontology|December 13, 2000
Neuronal plasticity and stressor toxicity during agingG J Brewer
The American Journal of Gastroenterology|February 18, 1999
Zinc therapy induction of intestinal metallothionein in Wilson's diseaseG J Brewer
Journal of Neurochemistry|July 1, 1996
Thrombin causes cell spreading and redistribution of beta-amyloid immunoreactivity in cultured hippocampal neuronsG J Brewer
Drugs|August 1, 1995
Practical recommendations and new therapies for Wilson's diseaseG J Brewer
Neurobiology of Aging|April 7, 1999
Age-related toxicity to lactate, glutamate, and beta-amyloid in cultured adult neuronsG J Brewer
The Journal of Laboratory and Clinical Medicine|September 11, 1999
Treatment of Wilson's disease with zincG J Brewer
Brain Research|June 19, 1995
Exogenous thrombin inhibits neuritogenesis in cultured neuroblastoma cells but not in rat hippocampal neuronsG J Brewer
Pageof 99

Showing results (11-20 of 985) with videos related to

Sort By:
Pageof 99
Experimental Biology and Medicine (Maywood, N.J.)|July 11, 2001
Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's diseaseG J Brewer
Current Opinion in Chemical Biology|April 26, 2003
Copper in medicineGeorge J Brewer
Journal of Cellular and Molecular Medicine|May 28, 2003
Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammationG J Brewer
Experimental Gerontology|December 13, 2000
Neuronal plasticity and stressor toxicity during agingG J Brewer
The American Journal of Gastroenterology|February 18, 1999
Zinc therapy induction of intestinal metallothionein in Wilson's diseaseG J Brewer
Journal of Neurochemistry|July 1, 1996
Thrombin causes cell spreading and redistribution of beta-amyloid immunoreactivity in cultured hippocampal neuronsG J Brewer
Drugs|August 1, 1995
Practical recommendations and new therapies for Wilson's diseaseG J Brewer
Neurobiology of Aging|April 7, 1999
Age-related toxicity to lactate, glutamate, and beta-amyloid in cultured adult neuronsG J Brewer
The Journal of Laboratory and Clinical Medicine|September 11, 1999
Treatment of Wilson's disease with zincG J Brewer
Brain Research|June 19, 1995
Exogenous thrombin inhibits neuritogenesis in cultured neuroblastoma cells but not in rat hippocampal neuronsG J Brewer
Pageof 99